Sign In
Buy CRON
$2.71
-0.0200 (-0.733%)
At Close: Jun 03, 2026
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
02:25pm, Wednesday, 04'th Feb 2026
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industr
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
02:30pm, Monday, 02'nd Feb 2026
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord
International Vector Equity Portfolio Buys 10,939 Shares of Cronos Group Inc (CRON)
04:38pm, Monday, 19'th Jan 2026
Summary International Vector Equity Portfolio raised its stake in Cronos Group Inc (CRON) by 5.69%, purchasing 10,939 shares to own 203,179 shares valu
3 Marijuana Stocks For Investors To Make Money In 2026
11:55am, Wednesday, 14'th Jan 2026
Finding the best marijuana stocks in the stock market today may be easier than you think. At one time, it was a simple task to determine which cannabis companies were better to invest in. Even with th
Eni's Cronos Development May Add New Gas Volumes to Europe From 2027
12:40pm, Friday, 09'th Jan 2026
E considers moving ahead with the Cronos gas project off Cyprus, which could supply natural gas to Europe by 2027.
Marijuana industry taking fight against Wall Street blockades straight to Trump
07:00am, Friday, 09'th Jan 2026
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed
Best Canadian Cannabis Stocks to Watch Entering 2026
10:00am, Tuesday, 06'th Jan 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
09:21am, Wednesday, 31'st Dec 2025
Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 investors.
Cronos: A Standout Balance Sheet Among Its Peers
09:32am, Tuesday, 30'th Dec 2025
Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior balance sheet. This superiority is a result of a 2019 investment by Altria
2 Marijuana Stocks To Watch For Better Investing In 2026
01:05pm, Sunday, 28'th Dec 2025
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te
Cronos Group (TSE:CRON) Shares Up 0.3% – Still a Buy?
04:47am, Sunday, 28'th Dec 2025
Shares of Cronos Group Inc. (TSE: CRON - Get Free Report) shot up 0.3% on Friday. The stock traded as high as C$3.76 and last traded at C$3.76. 81,193 shares were traded during trading, a decline of 6
3 Marijuana Stocks To Watch In 2026
01:58pm, Friday, 26'th Dec 2025
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af
Marijuana Stocks To Watch After The Holidays
11:52am, Wednesday, 24'th Dec 2025
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
11:35am, Monday, 22'nd Dec 2025
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
06:52pm, Friday, 19'th Dec 2025
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff
